Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action

Neha Bansal, Estela Azeka, Cindy Neunert, John S. Kim, Jenna Murray, Lindsay May, Christa Kirk, Angela Lorts, David Rosenthal, Christina VanderPluym

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

With growing number of pediatric cases of COVID-19, a unique hyper-inflammatory syndrome, linked to SARS-CoV-2 infection, has emerged in children referred to as multisystem inflammatory syndrome in children (MIS-C). This Kawasaki Disease (KD)-like illness has been described across the world. This syndrome shares features of KD, toxic shock syndrome, and macrophage activation syndrome and is associated with significantly elevated inflammatory markers. Everyday there are new data emerging improving the care of these patients. The Advanced Cardiac Therapies Improving Outcomes Network (ACTION) is a collaborative network designed to improve the outcomes of pediatric patients with end-stage heart failure and involves centers from across North America. The committee gathered information concerning COVID-19 anticoagulation practices at various centers and harmonized the data to formulate a set of recommendations.

Original languageEnglish (US)
Pages (from-to)1635-1639
Number of pages5
JournalPediatric Cardiology
Volume42
Issue number7
DOIs
StatePublished - Oct 2021

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action'. Together they form a unique fingerprint.

Cite this